As we approach the midpoint of 2026, the European supplement industry finds itself navigating a complex web of regulatory updates and changes. These developments have far-reaching implications, impacting everything from product formulations to marketing strategies and compliance plans. In this article, I'll delve into these updates, offering my insights and analysis on how they shape the future of the industry.
Ingredients Under the Microscope
One of the most significant areas of focus is the regulatory scrutiny being placed on various supplement ingredients. Berberine, hydroxycitric acid (HCA), and monacolin K from red yeast rice are all undergoing safety reviews, with potential bans or restrictions looming. The industry is also keeping a close eye on ashwagandha, CBD, and caffeine, although formal safety assessments for these ingredients have yet to begin. It's a delicate balance, as companies must navigate the fine line between innovation and regulatory compliance.
What makes this particularly fascinating is the potential impact on consumer choices. With certain ingredients facing restrictions or bans, companies will need to adapt their formulations, which could lead to a shift in the market dynamics and consumer preferences.
Novel Foods and Health Claims
The European Commission's updates to the EU Novel Food Catalogue have also brought about some interesting developments. CBD, for instance, has faced multiple rejections, while botanical extracts like gotu kola and wild oregano have been deemed novel, restricting their use in food supplements. On the other hand, pomegranate extract and whey protein concentrate with alpha-lactalbumin have been classified as non-novel, ensuring their continued availability in the European market.
In terms of health claims, the landscape is equally dynamic. EFSA has evaluated over 2,300 claims, with a rejection rate of over 70%. So far this year, only one ingredient, oat-beta glucans, has received a positive health claim opinion. This highlights the stringent nature of the regulatory process and the challenges companies face in substantiating their health claims.
Microbial Safety and QPS List
The QPS (Qualified Presumption of Safety) list is another crucial aspect of the regulatory framework. It provides a positive list of microbes that have been evaluated for safety, streamlining the process for companies seeking market authorization for microorganisms. The list is regularly updated, with the latest period covering January to July 2026. This approach ensures that only safe and thoroughly assessed microbes are used in the food and feed chain.
New Legislative Horizons
The supplement industry is also bracing for new legislative developments. The European Commission's call for evidence on setting maximum permitted levels (MPLs) for vitamins and minerals in supplements and fortified foods is a significant step. This consultation process will shape the future of these products, impacting their formulation and marketing.
Additionally, the supplement industry is facing challenges under the new Packaging and Packaging Waste Regulation (PPWR). The ban on PFAS in food-contact packaging and the upcoming Design for Recycling (DFR) requirements are significant changes that the industry is advocating for a delay in implementation. The industry's concerns are valid, as these changes will require substantial adjustments to packaging practices and infrastructure.
Lastly, the new UK-EU Sanitary and Phytosanitary (SPS) agreement will bring the UK's agricultural, food safety, and environmental standards in line with the EU's rules. This alignment will impact ingredient suppliers, manufacturers, retailers, and testing laboratories, affecting various regulatory aspects.
In conclusion, the European supplement industry is undergoing a period of intense regulatory scrutiny and change. From ingredient safety reviews to novel food classifications and health claim evaluations, companies must stay agile and adaptable. The industry's ability to navigate these complex waters will shape its future success and the availability of certain products to consumers. Personally, I believe that staying informed and proactive in the face of these regulatory challenges is key to thriving in this dynamic landscape.
